Nanomaterial-based drug delivery systems (NBDDS) are widely used to improve the safety
and therapeutic efficacy of encapsulated drugs due to their unique physicochemical and …

The recent emergence of nanomedicine has revolutionized the therapeutic landscape and
necessitated the creation of more sophisticated drug delivery systems. Polymeric …

Cell-based drug delivery systems are new strategies in targeted delivery in which cells or
cell-membrane-derived systems are used as carriers and release their cargo in a controlled …

The development of atherosclerosis (AS) is closely linked to changes in the plaque
microenvironment, which consists primarily of the cells that form plaque and the associated …

In the past five decades, red blood cells (RBCs) have been extensively explored as drug
delivery systems due to their distinguishing potential in modulating the pharmacokinetic …

Atherosclerosis (AS) is a major pathological factor to cardiovascular diseases, wherein
reactive oxygen species (ROS) serve as the initiating link for the development of AS …

Objective. The off‐target effects and severe side effects of PPARα and LXRα agonists greatly
limit their application in atherosclerosis (AS). Therefore, this study intended to use …

Today, cardiovascular diseases are among the biggest public health threats worldwide.
Atherosclerosis, a chronic inflammatory disease with complex aetiology and pathogenesis …

The properties of nanomaterials make them promising and advantageous for use in drug
delivery systems, but challenges arise from the immune system's recognition of exogenous …

Cell‐based nanotherapy holds great potential to transform diagnosis and treatment patterns
for human diseases, especially for cardiovascular diseases (CVDs). Surface coating with …